CRC Credit Research Compendium
Menu
日本語English

Issuer Credit Research

Issuer Flash: Shanghai Commercial Bank Limited

Issuer: Shanghai Commercial Bank | Document: Issuer Flash | Date: 2026-10-06 | Event: H1 2026 Results

Report date: 2026-10-06 Event date: 2026-06-30 Event title: H1 2026 Results: Lower Credit Costs, Incomplete Recovery

1. Flash Conclusion

Shanghai Commercial Bank, the Hong Kong deposit-taking bank with operations in mainland China, the United States and the United Kingdom, reported a substantial improvement in first-half earnings as credit impairment fell. Profit more than doubled to HK$1.49bn, and Stage 3 customer loans declined to HK$3.64bn. This is a positive change from the May 2026 issuer_summary's assessment of continuing asset-quality deterioration, supported by an actual reduction in problem-loan balances rather than loan growth alone.

The improvement remains incomplete. Loans overdue for more than one year increased, US problem assets remain concentrated, and the improvement in profit chiefly reflects lower impairment rather than a recovery in net interest income. Capital and deposit funding continue to provide substantial protection for senior creditors, while the recovery of stressed assets and the durability of lower credit costs matter particularly for Tier 2 investors. The results support a more constructive assessment of near-term loss absorption, but do not establish that CRE losses have peaked or justify a new instrument recommendation without current ratings and pricing.

2. Results and Date Basis

The official statement covers the six months ended June 30, 2026 and the consolidated bank group. The interim financial statements are unaudited and independently reviewed by PwC; the regulatory disclosures are unaudited and use the regulatory consolidation perimeter. August 19 is the board approval and independent review date. An independent public posting date has not been confirmed, so the Event date above denotes the period end, not a verified release date.

HK$bn unless stated H1 2025 H1 2026 Credit meaning
Net interest income 2.158 2.000 Down 7.3%; the core income base remains under pressure
Net fee and commission income 0.370 0.475 Growth cushions interest-income weakness
Operating expenses 1.101 1.113 Limited increase, but lower income lifts the cost/income ratio
Operating profit before credit impairment, calculated 2.128 1.910 Down 10.2%, almost entirely from lower property-sale gains
Credit impairment losses 1.455 0.211 The principal driver of earnings improvement
Profit for the period 0.705 1.486 More internal earnings available to absorb losses
Net interest margin 2.00% 1.87% Lower rates and loan yields constrain recurring earnings

Pre-impairment operating profit adds credit impairment losses to reported operating profit. Its HK$217m decline largely reflects property-sale gains falling HK$214m. Excluding only those gains, the measure was approximately flat at HK$1.80bn; this limited adjustment is not a fully normalized recurring-profit measure. Comparisons are six months against six months, not full-year forecasts.

3. Recovery Progress Has Not Removed the Legacy Risk

Stage 3 loans, excluding trade bills and other eligible bills, fell 8.1% from HK$3.96bn at end-2025 to HK$3.64bn. The corresponding ratio declined from 5.76% to 5.09%, helped both by the smaller impaired balance and the larger loan denominator. Management reports a 5.08% NPL ratio using total gross customer loans, including bills; the slightly different figure should not be conflated with the note's denominator. Gross customer loans including bills increased 4.1% to HK$71.59bn, reversing the prior year's contraction.

Management attributes progress to intensified recovery and disposal work. The balance-sheet evidence supports some improvement, but it does not provide a complete borrower-level bridge separating repayments, disposals, write-offs and migration. A lower ending Stage 3 balance therefore cannot establish that all reductions reflect cash recoveries or that future losses will be limited.

The US portfolio remains the largest source of impaired loans. US Stage 3 balances fell from HK$2.56bn to HK$2.38bn, but still represent a calculated 65.6% of group Stage 3 loans. They equal 13.6% of the US customer-loan portfolio, whose total balance was almost unchanged at HK$17.50bn. Stage 3 allowances cover approximately 21.5% of US Stage 3 balances. That ratio excludes collateral and cannot by itself quantify a provision shortfall; it does show why property valuations, enforcement costs and realizable proceeds remain central to ultimate loss severity.

There is also an unfavorable aging signal. Total loans overdue more than three months declined to HK$3.11bn, but balances overdue more than one year rose 25.6% to HK$2.50bn. These older loans now represent about 80% of the over-three-month overdue stock. In Hong Kong, over-three-month arrears increased to HK$1.06bn from HK$0.81bn even as local Stage 3 balances fell. Aggregate collateral values do not eliminate the risk of delayed collections, legal friction or asset-specific markdowns. The lower impairment expense is a period flow: group Stage 3 allowance stock actually rose from HK$804m to HK$838m. Neither that increase nor collateral totals prove adequacy. Headline problem assets have declined, but residual recovery risk persists.

4. Strong Buffers, Continuing Margin Pressure

Balance-sheet metric End-2025 June 2026
Gross customer loans, HK$bn, including bills 68.79 71.59
Customer deposits, HK$bn 175.13 173.39
Loan/deposit ratio 39.3% 41.3%
Stage 3 loans, HK$bn, excluding bills 3.96 3.64
Stage 3 ratio, excluding bills 5.76% 5.09%
CET1 ratio, regulatory scope 27.3% 27.0%
Total capital ratio, regulatory scope 30.4% 30.0%

Deposits declined 1.0%, but remain more than twice gross customer loans. The low loan/deposit ratio limits dependence on wholesale loan funding, although it does not measure depositor stability or every source of liquidity risk. Demand/current and savings deposits together comprise a calculated 30.5% of total customer deposits; time, call and notice deposits remain dominant. Depositor concentration and currency-specific stress liquidity have not been established from this event review.

The second-quarter LMR was 84.7%, the first-half average was 84.8%, and the end-June CFR was 273.2%. These are the applicable category 2/2A measures; the bank's disclosure marks LCR and NSFR as not applicable. CET1 capital increased to HK$37.89bn, but RWA increased faster, from HK$134.10bn to HK$140.45bn, reducing the CET1 ratio slightly. Profit accumulation is thus strengthening the capital amount without producing a rising ratio during renewed lending and balance-sheet repositioning.

Fee growth from life-insurance commissions and investment products, together with increased FX income, substantially offset NII pressure in the property-gain-adjusted operating comparison. The cost/income ratio nevertheless rose to 36.8% from 34.1%. Durability matters: fees and trading are not assured, and the lower impairment charge must survive future defaults.

FVOCI investment securities increased to HK$77.01bn from HK$68.33bn as management sought higher-yielding, high-rated bonds. OCI reflects both debt and equity exposure: gross fair-value decreases were HK$303m on investment securities and HK$523m on equity investments. The combined net FVOCI movement after tax and other adjustments was negative HK$780m, contributing to total OCI of negative HK$669m. Management identifies Bank of Shanghai shares as the chief contributor. Equity still rose, but comprehensive income of HK$816m was below net profit. Monitor duration and credit risk on debt holdings, and valuation risk on strategic equities separately.

5. Bondholder Implications and Next Checks

For senior bank credit, improving impairment and the continuing deposit, capital and liquidity buffers reduce the immediate pressure evident in the 2025 results. For the existing US$350m Tier 2 notes due 2033, described in the prior summary, stronger internal earnings are also helpful. They do not change subordination, non-viability loss absorption or the distinction between the February 2028 first optional call and contractual maturity. Current instrument ratings and call economics have not been refreshed, and the call remains an issuer option subject to regulatory approval.

The next disclosure should be judged against cash recoveries and write-offs, not only the reported impaired ratio. Priorities are the US Stage 3 balance, Hong Kong arrears, the over-one-year overdue stock, collateral realizations, and whether the low impairment run rate survives a full year. Loan growth and increased securities holdings should be assessed together with deposit composition, RWA and OCI. Current primary rating-agency views and Tier 2 pricing remain required before a security-specific investment conclusion. No new evidence establishes a legal guarantee from the parent or the Three Shanghai Banks alliance.

6. Sources